logo

Exhibiting at Propak Asia 2024

BITEC, Bangkok
11 Jun - 14 Jun, 2024

Product Offerings

Product Categories:

Prescription Drugs, Diagnostic Products

Products:

TERIBONE™ (teriparatide acetate), RECLAST™ (zoledronic acid), ELCITONIN™ (elcatonin) Injection 20S, RECOMODULIN™ (thrombomodulin alpha), CRESEMBA™(isavuconazonium sulfate), DOPTELET® (avatrombopag maleate), EMPAVELI® (pegcetacoplan), KEVZARA® (sarilumab), PLAQUENIL® (hydroxychloroquine sulfate), BREDININ™ (mizoribine), FLIVAS™ (naftopidil), TOLEDOMIN™ (milnacipran hydrochloride), ERIL™ (fasudil hydrochloride hydrate), FAMVIR™ (famciclovir)

Asahi Kasei Pharma Corporation is a subsidiary of Asahi Kasei Corporation, specializing in the discovery, development, manufacture, and delivery of pharmaceuticals and diagnostic products. Founded in 2003, the company focuses on providing innovative healthcare solutions in fields such as musculoskeletal disorders, pain management, emergency and intensive care, and the immune system. With a commitment to improving health and quality of life, Asahi Kasei Pharma operates globally, leveraging advanced research and development capabilities.